TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35086790

Group type: EXPERIMENTAL
Intervention: OligoG (1050 mg daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33524488

Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 8014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8014

Group type: EXPERIMENTAL
Intervention: Adrenaline and Placebo
Number of subjects: 8014
Study: 32723265

Group type: EXPERIMENTAL
Intervention: Physical therapy and an oral integrator (Micronil Dol®) composed of acetyl‐L‐carnitine, α‐lipoic acid, quercetin, bromelain, pantothenic acid, C and B1 and B2 and B6 and B12 vitamins
Number of subjects: 36

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 36
Study: 33258426

Group type: EXPERIMENTAL
Intervention: Inoculated with a 3 mm diameter PDA plug from the colony margin of Neofusicoccum batangarum
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control plants treated with PDA plugs only
Number of subjects: 16
Study: 36122263

Group type: EXPERIMENTAL
Intervention: Unilateral PKP
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bilateral PKP
Number of subjects: 72
Study: 34424730

Group type: EXPERIMENTAL
Intervention: Weekly rifapentine‐isoniazid for 3 months (n=3610)
Number of subjects: 4014

Group type: COMPARATOR
Intervention: Daily isoniazid for 6 months (n=404)
Number of subjects: 4014

Group type: EXPERIMENTAL
Intervention: Rifapentine‐isoniazid regimen given annually for 2 years (n=1808)
Number of subjects: 4014

Group type: EXPERIMENTAL
Intervention: Rifapentine‐isoniazid regimen given once (n=1802)
Number of subjects: 4014
Study: 35314388

Group type: EXPERIMENTAL
Intervention: Intralesional macular atrophy (ILMA)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Hyperreflective material (HRM)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Intraretinal fluid (IRF)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Subretinal fluid (SRF)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Pigment epithelial detachment (PED)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Disorganization of outer retinal layers (DROL)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Best corrected visual acuity (BCVA)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Presence of ILMA
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Presence of HRM
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Foveal pigment epithelial detachment (PED)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Low luminance visual acuity (LLVA)
Number of subjects: 532
Study: 33626568

Group type: EXPERIMENTAL
Intervention: Participants reminded of the pandemic before reporting Trump support
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Republicans concerned about the pandemic
Number of subjects: 1763
Study: 32470440

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide with rituximab
Number of subjects: 0
Study: 35687710

Group type: EXPERIMENTAL
Intervention: Hatha yoga for 60 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-intensity exercise for 60 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group-based health-and-wellness education for 45 minutes
Number of subjects: 0
Study: 33599143

Group type: EXPERIMENTAL
Intervention: Mechanical mitral valve replacement
Number of subjects: 2812

Group type: EXPERIMENTAL
Intervention: Mechanical aortic valve replacement (AVR)
Number of subjects: 2812

Group type: COMPARATOR
Intervention: Bioprosthetic mitral valve replacement
Number of subjects: 2812

Group type: COMPARATOR
Intervention: Bioprosthetic aortic valve replacement (AVR)
Number of subjects: 2812
Study: 32773581

Group type: EXPERIMENTAL
Intervention: 80 mg of aspirin daily during pregnancy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo daily during pregnancy
Number of subjects: 90
Study: 35590177

Group type: EXPERIMENTAL
Intervention: Frequent assessment conditions
Number of subjects: 235

Group type: COMPARATOR
Intervention: Infrequent assessment conditions
Number of subjects: 235
Study: 35852582

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RDN and Sham control
Number of subjects: 0
Study: 32326796

Group type: EXPERIMENTAL
Intervention: Ticagrelor (aspirin plus ticagrelor)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Clopidogrel (aspirin plus clopidogrel)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Ticagrelor and Clopidogrel
Number of subjects: 352
Study: 33512618

Group type: EXPERIMENTAL
Intervention: audio format
Number of subjects: 124

Group type: COMPARATOR
Intervention: unimodal formats (text, audio, pictures)
Number of subjects: 124

Group type: COMPARATOR
Intervention: multimodal format (text/audio with pictures)
Number of subjects: 124
Study: 33243806

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus erlotinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus erlotinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus erlotinib (price reduction scenario)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erlotinib (price reduction scenario)
Number of subjects: 0
Study: 34863009

Group type: EXPERIMENTAL
Intervention: Fermentation with Lactiplantibacillus plantarum CRL2211 and Weissella paramesenteroides CRL2182 for 24 hours at 37°C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fermented doughs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other processing methods (soaking, germination, cooking)
Number of subjects: 0
Study: 34895292

Group type: COMPARATOR
Intervention: Non-antibacterial therapeutic clothing (Group A)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Chitosan-based therapeutic clothing (Group B)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Silver-based therapeutic clothing (Group C)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 165
Study: 35854255

Group type: EXPERIMENTAL
Intervention: Concentric cycling (CONC) for 12 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC) for 12 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined eccentric/concentric cycling (ECC/CONC) for 12 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Molecular adaptations regulating muscle growth
Number of subjects: 100
Study: 34259404

Group type: EXPERIMENTAL
Intervention: Auricular intradermal needling
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Auricular point sticking
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34851219

Group type: EXPERIMENTAL
Intervention: self‐defense victim
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: victim
Number of subjects: 505

Group type: COMPARATOR
Intervention: control
Number of subjects: 505
Study: 33751288

Group type: EXPERIMENTAL
Intervention: Masculine children
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Feminine children
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control children
Number of subjects: 400
Study: 33154793

Group type: EXPERIMENTAL
Intervention: Hyrax expander
Number of subjects: 42

Group type: COMPARATOR
Intervention: Haas expander
Number of subjects: 42
Study: 33589633

Group type: EXPERIMENTAL
Intervention: Pharmacological GDF15
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endurance exercise (physiological GDF15 induction)
Number of subjects: 0
Study: 33377442

Group type: EXPERIMENTAL
Intervention: Good Research for Comparative Effectiveness (GRACE) Checklist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IMI GetReal RWE Navigator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Center for Medical Technology Policy (CMTP) RWE Decoder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CER Collaborative tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real World Evidence Assessments and Needs Guidance (REAdi) tool
Number of subjects: 0
Study: 36327755

Group type: EXPERIMENTAL
Intervention: Non-rebreather mask combined with low-flow nasal cannula (NRB + NC)
Number of subjects: 110

Group type: COMPARATOR
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 110
Study: 35958552

Group type: EXPERIMENTAL
Intervention: Low-dose rituximab (600 mg)
Number of subjects: 2
Study: 34174084

Group type: EXPERIMENTAL
Intervention: Process Evaluation (PE)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flexible and pragmatic approaches (e.g., interviews instead of focus groups)
Number of subjects: 6
Study: 34916086

Group type: EXPERIMENTAL
Intervention: Apalutamide 240 mg/d
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study: 33788458

Group type: EXPERIMENTAL
Intervention: Cognitive training and scalp acupuncture at Baihui (GV 20), Sishencong (EX‐HN 1), Zhisanzhen and Niesanzhen, needles retained for 6 hours, treated once a day, 6 times a week for 3 courses of one month each.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cognitive training (control group).
Number of subjects: 70
Study: 33931919

Group type: COMPARATOR
Intervention: Postoperative surgery alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil
Number of subjects: 0
Study: 32203007

Group type: EXPERIMENTAL
Intervention: PIPA-treated RBC exchange transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard RBC exchange transfusion
Number of subjects: 0
Study: 34654929

Group type: EXPERIMENTAL
Intervention: Drug arm
Number of subjects: 70
Study: 32966568

Group type: EXPERIMENTAL
Intervention: Social-marketing program focused on the possible consequences of the reporting decision
Number of subjects: 468

Group type: COMPARATOR
Intervention: Traditional concussion-symptom education based on the NCAA's publication
Number of subjects: 468

Group type: COMPARATOR
Intervention: Revised symptom education with less clinical delivery
Number of subjects: 468
Study: 35500786

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: High dose-rate brachytherapy (HDR) monotherapy
Number of subjects: 648

Group type: COMPARATOR
Intervention: High dose-rate brachytherapy (HDR) boost
Number of subjects: 648
Study: 32829654

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35469481

Group type: EXPERIMENTAL
Intervention: Mepivacaine injection into the temporalis tendon
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nerve growth factor injection into the temporalis tendon
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nerve growth factor injection
Number of subjects: 40
Study: 32155399

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Suboptimal cytoreduction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Presence of pelvic pain at presentation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Stage III
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Type of cytoreduction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Pathological subtypes
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Adjuvant treatment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Absence of pelvic pain at diagnosis
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: FIGO IIIC stage
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Inadequate adjuvant treatment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Pathological type of clear cell cancer
Number of subjects: 65
Study: 35409444

Group type: EXPERIMENTAL
Intervention: Literacy group
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 25

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 25
Study: 33085560

Group type: EXPERIMENTAL
Intervention: Lateral rectus plication (n = 27)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Lateral rectus resection (n = 30)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Lateral rectus plication
Number of subjects: 57

Group type: COMPARATOR
Intervention: Lateral rectus resection
Number of subjects: 57
Study: 34822140

Group type: EXPERIMENTAL
Intervention: MiBoFlo Thermoflo®
Number of subjects: 54

Group type: COMPARATOR
Intervention: LipiFlow®
Number of subjects: 54
Study: 33583149

Group type: EXPERIMENTAL
Intervention: Budesonide and 0.1% tretinoin for 12 weeks (TRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Budesonide for 24 weeks (CTR)
Number of subjects: 30
Study: 33060100

Group type: EXPERIMENTAL
Intervention: Gadobutrol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Gadobutrol and Gadoterate meglumine
Number of subjects: 32
Study: 35426149

Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week duration)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (two 2-hour lectures about mindfulness over 8 weeks)
Number of subjects: 60
Study: 33631357

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg orally daily for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32363556

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (10,000 IU twice weekly) combined with clomiphene citrate (50 mg twice daily for 5 days)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo with calcium (1250 mg twice daily) combined with clomiphene citrate (50 mg twice daily for 5 days)
Number of subjects: 186
Study: 34190883

Group type: EXPERIMENTAL
Intervention: Telephone intervention (six telephone interventions over three months)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (conventional follow-up)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intergroup analysis after telephone intervention
Number of subjects: 102
Study: 32386421

Group type: EXPERIMENTAL
Intervention: Rosuvastatin treatment for 18 months
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Use of biologic DMARDs (bDMARDs) at follow‐up
Number of subjects: 84
Study: 35836172

Group type: EXPERIMENTAL
Intervention: Spot the Difference Teaching Method (SDTM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Flipped Learning (Control)
Number of subjects: 0
Study: 34412908

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily until progression or unacceptable toxicity
Number of subjects: 41
Study: 35717038

Group type: EXPERIMENTAL
Intervention: Mechanochemical ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thermal ablation
Number of subjects: 0
Study: 34062587

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Betalactam-antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-treatment patients
Number of subjects: 0
Study: 35897322

Group type: EXPERIMENTAL
Intervention: Outdoor physical activity program
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 34468794

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg twice daily)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (no vitamin E)
Number of subjects: 140
Study: 32690274

Group type: EXPERIMENTAL
Intervention: CTC detection and routine re-examination (CTC group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Routine re-examination (Control group)
Number of subjects: 135
Study: 33407490

Group type: EXPERIMENTAL
Intervention: Low dose walnut (30 g/d)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High dose walnut (60 g/d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (non-edible gift)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: All groups (low dose, high dose, control)
Number of subjects: 210
Study: 32192623

Group type: EXPERIMENTAL
Intervention: Bupropion therapy along with standard counselling
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Enhanced counseling
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Standard counseling
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 517
Study: 34714969

Group type: COMPARATOR
Intervention: Abelacimab (30-150 mg) intravenous single doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abelacimab (120 mg and 180 mg) subcutaneous monthly doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abelacimab (intravenous and subcutaneous)
Number of subjects: 0
Study: 34133394

Group type: EXPERIMENTAL
Intervention: CL‐Deb (debridement)
Number of subjects: 190

Group type: COMPARATOR
Intervention: CL‐noDeb (observation)
Number of subjects: 190
Study: 36150583

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 192

Group type: COMPARATOR
Intervention: Milrinone
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Supraventricular arrhythmic events
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Ventricular arrhythmic events
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion
Number of subjects: 192
Study: 34344674

Group type: EXPERIMENTAL
Intervention: Summer STRIPES
Number of subjects: 72

Group type: COMPARATOR
Intervention: School services as usual
Number of subjects: 72
Study: 32538455

Group type: EXPERIMENTAL
Intervention: Nutrition knowledge presentation intervention
Number of subjects: 642

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 642
Study: 34806782

Group type: EXPERIMENTAL
Intervention: NBM DBS
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GPi DBS
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NBM stimulation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Volume of tissue activated in the left NBM
Number of subjects: 6
Study: 33743343

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 36432401

Group type: EXPERIMENTAL
Intervention: Dietary prescription with nutritional recommendations, nutritional education program based on playful strategies, suggestions of typical and accessible Brazilian foods and intensive monitoring
Number of subjects: 2360

Group type: COMPARATOR
Intervention: Conventional nutritional counseling
Number of subjects: 2360

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 2360

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2360
Study: 34481326

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) nasal spray
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 32561410

Group type: EXPERIMENTAL
Intervention: Colonoscopy with CADe
Number of subjects: 40

Group type: COMPARATOR
Intervention: Colonoscopy without CADe
Number of subjects: 40
Study: 35482329

Group type: EXPERIMENTAL
Intervention: Moderate intensity cycling
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Light intensity cycling
Number of subjects: 114

Group type: COMPARATOR
Intervention: Both exercise groups
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: CRF change
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: BOLD‐CVR
Number of subjects: 114
Study: 34486356

Group type: EXPERIMENTAL
Intervention: Cover crop residue from Calopogonium mucunoides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cover crop residue (general)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no cover crop residue)
Number of subjects: 0
Study: 32742637

Group type: EXPERIMENTAL
Intervention: Contingent financial incentive (£10 note in addition to a routinely provided £10 voucher)
Number of subjects: 434

Group type: COMPARATOR
Intervention: No contingent financial incentive (control)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Contingent financial incentive
Number of subjects: 434
Study: 35739046

Group type: EXPERIMENTAL
Intervention: Self‐Management Multidisciplinary Program (MP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 96
Study: 33617961

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC) - 4 cycles of 5 min intermittent leg ischemia and 5 min reperfusion
Number of subjects: 55

Group type: COMPARATOR
Intervention: SHAM preconditioning
Number of subjects: 55
Study: 34101856

Group type: EXPERIMENTAL
Intervention: Watchman device
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: LAmbre device
Number of subjects: 97
Study: 32945627

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (daily dosage not specified) for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 0
Study: 36154873

Group type: EXPERIMENTAL
Intervention: Programmed aerobic and strength training once a week for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 616497132

Group type: EXPERIMENTAL
Intervention: PEM 1%
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 32710585

Group type: EXPERIMENTAL
Intervention: Herbal cream (cream A) applied topically twice-daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control cream (cream B) applied topically twice-daily
Number of subjects: 35
Study: 33879077

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Eculizumab (resumed recommended dose after trial of weaning)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Eculizumab (initial treatment)
Number of subjects: 1
Study: 33012286

Group type: EXPERIMENTAL
Intervention: Apatinib
Number of subjects: 31
Study: 35578297

Group type: EXPERIMENTAL
Intervention: Shoe inserts
Number of subjects: 36
Study: 34763638

Group type: EXPERIMENTAL
Intervention: Biatrial ablation (BA) with coronary bypass (CB)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Left atrial ablation (LAA) with coronary bypass (CB)
Number of subjects: 116
Study: 33172136

Group type: EXPERIMENTAL
Intervention: 12-week CoD sprint training program (INT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regular basketball training (CON)
Number of subjects: 16
Study: 35241817

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (BP < 120/80 mmHg)
Number of subjects: 1074

Group type: COMPARATOR
Intervention: Standard blood pressure control (BP < 140/90 mmHg)
Number of subjects: 1074